While ur at #DDW2023 think about who would be great for this award! Jessica R Allegretti Edward Loftus James Lewis Stephen B. Hanauer, MD

Great #IBD discussion to close out the day #DDW23

#RedJournal Strong! 📕💪 CoEICs Millie Long and Jasmohan Bajaj with members of Editorial Board & ACG Prez DanielPambiancoMD in Chicago today! #DDW2023 #MostReadinRed

Summary of FMT trials in UC ⁦Ashwin,M.D⁩ ⁦Digestive Disease Week⁩

Higher steroid free remission on ups than on uste in a real word cohort per Rahul S. Dalal, MD, MPH Edward Barnes MD MPH Jessica R Allegretti

Check out our data on utilizing colonic washes to identify c.difficile colonization in #IBD patients undergoing colonoscopy The Allegretti Lab #DDW2023

Inspired by your #IBD colleagues during Gta Kostenlos? Then now's the time to nominate them for their pioneering contributions in the fight to overcome #crohns & #colitis: bit.ly/3KNvYxE Deadline: May 21 Digestive Disease Week American Gastroenterological Association (AGA) @gastroenterology

Thrilled to present the phase 3 induction data for guselkumab ( anti- IL-23) in patients with moderate to severe #UC. Great to have safe effective options for #IBD patients #DDW23 JanssenUS JNJInnovative Medicine

Very proud of The Allegretti Lab member Rahul S. Dalal, MD, MPH who is presenting important data on pain medication use in #IBD on the big stage at #DDW23

Find me here Jessica R Allegretti, MD, MPH, FACG, AGAF

Treatment with #Rebyota ( Ferring Microbiome U.S.) did not affect concurrent #medication use in #patients with #inflammatoryboweldisease and recurrent #Clostridioidesdifficile infection, Jessica R Allegretti, MD, MPH, FACG, AGAF explains in this Healio video. #DDW23 Digestive Disease Week bit.ly/3I0dN5o

FDA approves first oral treatment for moderately to severely active Crohn’s disease fda.gov/drugs/news-eve…

Thanks for a great conference SPARTAN!

We love Lindsay Clarke, MD and are thrilled to have her on team #BrighamIBD and the The Allegretti Lab

Congratulations!! We are so lucky to have you with us next year! The Allegretti Lab member forever

Let’s hope this will move the needle to change clinical trial design and at least partially overcome an obstacle to recruitment in #IBD clinical trials American Gastroenterological Association (AGA) Jessica R Allegretti IOIBD

Our multicenter real-world experience w/ #upadacitinib induction for #UC in IBDJournal & CC360 🔑64% steroid-free remission 🔑84% clinical response 🔑62% endo response 🔑35% endo remission doi.org/10.1093/ibd/iz… Jessica R Allegretti, MD, MPH, FACG, AGAF The Allegretti Lab Brigham and Women's GI Edward Barnes MD MPH UNC Gastroenterology

Findings from a paper presented by Rahul S. Dalal, MD, MPH at #ACG2023 revealed upadacitinib was associated with a greater likelihood of achieving clinical response, steroid-free clinical remission, and endoscopic remission compared to ustekinumab. Read more: hcplive.com/view/study-com…

Great discussions underway at #IBD A to Z #CCCongress24 reviewing all of our latest therapies. Jessica R Allegretti, MD, MPH, FACG, AGAF Bincy Abraham, MD, MS David Schwartz Florian Rieder Christina Ha MD Sara Horst MD, MPH, FACG

Jessica R Allegretti, MD, MPH, FACG, AGAF teaching us the basics on fecal microbiota transplants FMT and what your practice and patients need to know ACG